Article
Tumor thymidylate synthase 1494del6 genotype as a prognostic factor in colorectal cancer patients receiving fluorouracil-based adjuvant treatment.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 1 Apr 2006
Dotor Emma, Cuatrecases Miriam, Martínez-Iniesta María, Navarro Matilde, Vilardell Felip, Guinó Elisabeth, Pareja Laura, Figueras Agnés, Molleví David G, Serrano Teresa, de Oca Javier, Peinado Miguel A, Moreno Víctor, Germà Josep Ramón, Capellá Gabriel, Villanueva Alberto
Abstract excerpt
PURPOSE: The purpose of this study was to analyze the value of germline and tumor thymidylate synthase (TS) genotyping as a prognostic marker in a series of colorectal cancer patients receiving adjuvant fluorouracil (FU) -based treatment. PATIENTS AND METHODS: One hundred twenty-nine colorectal cancer patients homogeneously treated with FU plus levamisole or leucovorin in the adjuvant setting were included. TS...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
